MedPath

An Intervention Program to Control Diabetes

Phase 4
Completed
Conditions
Diabetes Mellitus, Type 2
Registration Number
NCT00543621
Lead Sponsor
Abbott Nutrition
Brief Summary

Study to evaluate the effectiveness of a structured intervention to improve diabetes control.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • informed consent
  • 18-70 adults
  • Type 2 Diabetes
  • Males and non-pregnant females
Exclusion Criteria
  • Use of exogenous insulin for glucose control
  • Use of medications or supplements for weight loss
  • Advanced diabetes complications
  • Recent history of cardiovascular event

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
HbA1c, Fasting blood glucose,blood pressure, weight loss24 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Huandong Hospital

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath